CryoLife, Inc. (CRY) Reports In-Line Q3 EPS, Offers Insight on FY11 Outlook
CryoLife, Inc. (
CryoLife, Inc. sees FY2011 EPS of $0.32-$0.34, versus the consensus of $0.38. The Company expects total revenues for the full year of 2011 to be slightly below the lower end of its range of between $122.0 million and $125.0 million.
NYSE: CRY) reported Q3 adjusted EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $30.64 million.
CryoLife, Inc. sees FY2011 EPS of $0.32-$0.34, versus the consensus of $0.38. The Company expects total revenues for the full year of 2011 to be slightly below the lower end of its range of between $122.0 million and $125.0 million.